Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Craniocerebral Injuries

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Craniocerebral Injuries in 2 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bissette, G1
Rukskul, P1

Reviews

1 review available for n-methyl-3,4-methylenedioxyamphetamine and Craniocerebral Injuries

ArticleYear
Does Alzheimer's disease result from attempts at repair or protection after transient stress?
    Journal of Alzheimer's disease : JAD, 2009, Volume: 18, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Craniocerebral Tr

2009

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Craniocerebral Injuries

ArticleYear
Ecstasy (MDMA) ingestion related with severe hyponatremia in patients with mild head injury.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88, Issue:1

    Topics: Adult; Craniocerebral Trauma; Hallucinogens; Humans; Hyponatremia; Male; N-Methyl-3,4-methylenedioxy

2005